Zogenix wins FDA nod for extended-release hydrocodone; UMass researchers jam up nanoparticles with long-term stability;

> Zogenix ($ZGNX) won FDA approval for its extended-release hydrocodone painkiller after a panel of experts said it wanted the administration to hold off. Story

> Researchers at the University of Massachusetts Amherst have kinetically trapped one liquid within another to be stable over a long period of time, a discovery that could have clear implications for drug delivery. More

> Phosphagenics ($PPGNY) welcomed positive Phase I results for its oxymorphone patch for pain management. Release

> Case Western Reserve University researchers accepted a grant from the National Science Foundation to make complex nanoparticles more easily reproducible for manufacturing. More